Naproxcinod -- Does This New Drug Mean That Safe Pain Relief Is at Hand?

Clinical Professor of Internal Medicine; Director of Hypertension Research, New York University School of Medicine, NYU Center for the Prevention of Cardiovascular Disease, New York, NY

Disclosure: Henry R. Black, MD, has disclosed the following relevant financial relationships:
Received grants for educational activities from: Novartis Pharmaceuticals Corporation; Daiichi Sankyo, Inc.; Pfizer Inc.
Served as an advisor or consultant for: Novartis Pharmaceuticals Corporation; Daiichi Sankyo, Inc.; InterCure, Inc.; Merck Sharp & Dohme; Gilead Sciences, Inc.